1. Home
  2. MTVA vs BOSC Comparison

MTVA vs BOSC Comparison

Compare MTVA & BOSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTVA
  • BOSC
  • Stock Information
  • Founded
  • MTVA 2014
  • BOSC 1990
  • Country
  • MTVA United States
  • BOSC Israel
  • Employees
  • MTVA N/A
  • BOSC N/A
  • Industry
  • MTVA
  • BOSC Computer Communications Equipment
  • Sector
  • MTVA
  • BOSC Telecommunications
  • Exchange
  • MTVA NYSE
  • BOSC Nasdaq
  • Market Cap
  • MTVA 18.9M
  • BOSC 19.7M
  • IPO Year
  • MTVA N/A
  • BOSC 1996
  • Fundamental
  • Price
  • MTVA $1.95
  • BOSC $3.79
  • Analyst Decision
  • MTVA Strong Buy
  • BOSC Strong Buy
  • Analyst Count
  • MTVA 1
  • BOSC 1
  • Target Price
  • MTVA $12.00
  • BOSC $5.00
  • AVG Volume (30 Days)
  • MTVA 337.7K
  • BOSC 63.1K
  • Earning Date
  • MTVA 11-07-2024
  • BOSC 11-27-2024
  • Dividend Yield
  • MTVA N/A
  • BOSC N/A
  • EPS Growth
  • MTVA N/A
  • BOSC 5.81
  • EPS
  • MTVA N/A
  • BOSC 0.38
  • Revenue
  • MTVA N/A
  • BOSC $40,448,000.00
  • Revenue This Year
  • MTVA N/A
  • BOSC $6.20
  • Revenue Next Year
  • MTVA N/A
  • BOSC N/A
  • P/E Ratio
  • MTVA N/A
  • BOSC $9.97
  • Revenue Growth
  • MTVA N/A
  • BOSC N/A
  • 52 Week Low
  • MTVA $1.51
  • BOSC $2.50
  • 52 Week High
  • MTVA $6.75
  • BOSC $4.20
  • Technical
  • Relative Strength Index (RSI)
  • MTVA N/A
  • BOSC 62.05
  • Support Level
  • MTVA N/A
  • BOSC $3.43
  • Resistance Level
  • MTVA N/A
  • BOSC $3.78
  • Average True Range (ATR)
  • MTVA 0.00
  • BOSC 0.25
  • MACD
  • MTVA 0.00
  • BOSC 0.02
  • Stochastic Oscillator
  • MTVA 0.00
  • BOSC 60.85

About MTVA METAVIA INC

MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

Share on Social Networks: